Skip to content
DraconiticResearch
Search Sources API
210,043 studies31 sourcesUpdated 32 min ago

Oncology

5,302 studies557 in 7 days2,546 in 30 days

Filters
Type
Date
Clear

Latest

5,302 studies

  1. Precision surgical oncology for hepatocellular carcinoma
    Takehiro Okabayashi, Motoyasu Tabuchi, Teppei Tokumaru +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  2. Recurrent thymoma-associated PRCA with persistent agranulocytosis: a case report and therapeutic considerations
    Antuo Wang, Yu Xia, Mengyuan Xin +4
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  3. Breaking the ERK1/2 negative feedback loop: avoiding reactivation and acquisition of resistance by ERK1/2 to anti-cancer agents
    Orel Slotki-Itzchakov, Sally Shpungin, Uri Nir
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  4. Radiation protection considerations for ultra-high dose rate proton beam FLASH research: consensus from multi-institutional experience
    Michael J. Taylor, Christopher Bayer, Gerard Paquet +10
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  5. Implications of cellular prion protein in tumor biology
    Ahmed Damra
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  6. Tumor-associated macrophages beyond M1/M2 in NSCLC: spatially organized programs, therapy resistance, and translational targeting
    Xiao-Long Wang, Ziheng Jiang, Qianqian Lu +1
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  7. M2 macrophage-derived exosomes and miR-132-3p promote gastric cancer cell aggressiveness and attenuate ferroptosis-related changes
    Tao Zhang, Yong Huang, Peng Cheng +4
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  8. Prognostic value of the neutrophil-to-lymphocyte ratio in patients with colorectal cancer undergoing chemotherapy: a systematic review and meta-analysis
    Yihui Zhang, Ning Ding, Yingchao Cui +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  9. Leptomeningeal metastasis of lung adenocarcinoma presenting as cauda equina syndrome: a case report and literature review
    Xiaofeng Chen, Haijuan Lv
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  10. Topical herbal medicine as treatment for chemotherapy-induced peripheral neuropathy: a systematic review of randomized controlled trials
    Carrie Shao, Cassie Shao, Andrew Haggarty +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  11. Three-dimensional anatomical reconstruction as a guideline-anchored framework for choosing between lung-sparing resection and image-guided ablation in deep subsolid pulmonary nodules: a thoracic surgeon’s perspective
    Zhe Li, Huixian Li
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  12. Ginsenoside Rb2 promotes p62-mediated LDHA autophagic degradation to inhibit H3K18la-dependent PD-L1 transcription in cervical cancer
    Xingwei Wang, Ziyue Zhang, Mei Chen +4
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  13. Clinical outcomes and prognostic factors of Ommaya reservoir-based intrathecal chemotherapy in lung cancer leptomeningeal metastasis: a retrospective cohort study
    Yuechao Yang, Mingtao Feng, Yu Xuan Ong +12
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  14. Number of examined lymph nodes and overall survival in intrahepatic cholangiocarcinoma: a population-based study suggesting a staging benefit
    Xuchang He, Wenhui An, Yangwei Chen +3
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  15. Case Report: lipoblastoma-like tumor of the tongue
    Li Yi, Haiyan Yang, Wenxin Wu
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  16. Correlation between circulating tumor cell levels and tumor response in patients with advanced hepatocellular carcinoma undergoing immunotherapy and molecular targeted therapy
    Jiangmin Zhou, Huifang Xiong, Honghao Zhou +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  17. Mechanisms of immune resistance in microsatellite-stable colorectal cancer
    Dongguang Niu, Peng Liu, Xinyu Chen +4
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  18. Integrating overall survival and health-related quality of life to prioritize first-line systemic therapies for unresectable advanced gastric cancer: a network meta-analysis
    Ji Wu, Zhigang Zheng, Xiping Shen +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  19. A logistic paradigm to predict molecular glioblastoma on clinical MRI
    Yousif Aldabbagh, Faheem Bhatti, Nitin Menon +7
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  20. Efficacy and toxicities of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel as first-line chemotherapy for unresectable pancreatic cancer: a systematic review and meta-analysis
    Chunle Hu, Li Zhan, Yanhui Li +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  21. ATF4 and SLC7A11 as biomarkers predicting progression and prognosis in lung adenocarcinoma
    Yanjie Liu, Dongli Guo, Daojuan Li +1
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  22. Case Report: Immune checkpoint inhibitor–induced hypophysitis presenting as acute paralytic ileus mimicking mechanical bowel obstruction in a patient affected by advanced non-small cell lung cancer
    Alice Baggi, Anna Adriani, Luca Carlofrancesco Ammoni +6
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  23. Tonsillar metastasis from hepatocellular carcinoma: a case report and literature review
    Jianhao Yang, Yujuan Dai, Lusheng Wen +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  24. Dynamic serum chloride trajectories predict short- and long-term mortality in patients with malignancies: a retrospective cohort study with external validation
    Ruming Zhao, Shaojun Yang
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  25. 5.0T multi-parametric diffusion MRI histogram analysis for prostate cancer pathology grading and adverse pathological factors
    Sen Xing, Ying Tan, Xinghua Liu +7
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC